Provided by Tiger Trade Technology Pte. Ltd.

Personalis

16.28
+0.11000.68%
Post-market: 16.280.00000.00%19:30 EDT
Volume:1.14M
Turnover:18.51M
Market Cap:1.74B
PE:-14.83
High:16.44
Open:16.38
Low:16.12
Close:16.17
52wk High:18.89
52wk Low:4.96
Shares:107.00M
Float Shares:72.63M
Volume Ratio:0.89
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-0.9107
ROE:-50.32%
ROA:-25.03%
PB:7.41
PE(LYR):-17.88

Loading ...

Personalis NeXT Personal ctDNA assay posts 100% longitudinal sensitivity for colorectal cancer recurrence in VICTORI study

Reuters
·
May 26

Analysts Are Bullish on These Healthcare Stocks: Personalis (PSNL), Eton Pharmaceuticals (ETON)

TIPRANKS
·
May 22

Personalis Inc - CMS Expands Medicare Coverage for Personalis Next Personal Test in Breast Cancer Monitoring - SEC Filing

THOMSON REUTERS
·
May 21

Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Personalis (PSNL)

TIPRANKS
·
May 20

Personalis NeXT Disease Test Approved for Expanded Coverage by Medicare, Medicaid

MT Newswires Live
·
May 20

Personalis secures fourth Medicare coverage decision for NeXT Personal

TIPRANKS
·
May 20

Personalis cites PREDICT-DNA study supporting NeXT Personal monitoring in breast cancer NAT

Reuters
·
May 20

Personalis Secures Fourth Medicare Coverage Decision for Next Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring

THOMSON REUTERS
·
May 20

Personalis Inc - Coverage NOW Includes Neoadjuvant Therapy Monitoring for Stage Ii-Iii Tnbc or Her2+ Breast Cancer

THOMSON REUTERS
·
May 20

Personalis Shareholders Back Directors, Auditor and Executive Pay

TIPRANKS
·
May 14

Personalis Gains Expanded Medicare Coverage for NeXT Personal

TIPRANKS
·
May 14

Personalis stockholders elect two Class I directors at annual meeting

Reuters
·
May 14

Sector Update: Healthcare Stocks Lean Lower Pre-Bell Wednesday

MT Newswires Live
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Nebius, US chipmakers, Assertio Holdings

Reuters
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Orla Mining, Personalis, Eos Energy

Reuters
·
May 13

Personalis Shares Rise on Medicare Coverage for Immunotherapy Monitoring

Dow Jones
·
May 13

Personalis Receives Medicare Coverage for Next Personal® for Immunotherapy Monitoring Across Late-Stage Solid Tumors

THOMSON REUTERS
·
May 13

Personalis wins expanded Medicare coverage for NeXT Personal immunotherapy monitoring test

Reuters
·
May 13

Personalis Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 13

Personalis price target lowered to $9 from $10 at Morgan Stanley

TIPRANKS
·
May 12